Shopping Cart
- Remove All
- Your shopping cart is currently empty
Otamixaban (FXV673) is a selective and highly effective Xa inhibitor that inhibits the generation of thrombin and can be used to study acute coronary syndrome.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $299 | In Stock |
Description | Otamixaban (FXV673) is a selective and highly effective Xa inhibitor that inhibits the generation of thrombin and can be used to study acute coronary syndrome. |
Targets&IC50 | TMPRSS2:18.7 × 10 μM |
In vitro | The HTS assay indicates that otamixaban shows inhibitory activity against TMPRSS2. IC50= 18.7 × 10 μM. Otamixaban in the Calu-3 cell line inhibits SARS-CoV-2 S-mediated viral entry. [5] |
In vivo | Otamixaban is highly efficacious in rodent, canine and porcine models of thrombosis showed in vivo experiments. Recent clinical findings indicate that Otamixaban is efficacious, safe, and well-tolerated in humans and therefore has considerable potential for the treatment of acute coronary syndrome. |
Alias | XRP 0673, RPR 130673, FXV-673, FXV673, FXV 673 |
Molecular Weight | 446.5 |
Formula | C25H26N4O4 |
Cas No. | 193153-04-7 |
Smiles | C(N[C@@H]([C@@H](CC1=CC(C(=N)N)=CC=C1)C(OC)=O)C)(=O)C2=CC=C(C=C2)C=3C=CN(=O)=CC3 |
Relative Density. | 1.25 g/cm3 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 40 mg/mL (89.59 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.